STOCK TITAN

Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Zoetis (NYSE: ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023. CEO Kristin Peck is scheduled to present at 1:30 p.m. PT and answer analyst questions. Investors can access a live audio webcast of the presentation through the company's investor relations site. A replay will also be available post-event. Zoetis, a leading animal health company, generated $7.8 billion in revenue in 2021 and operates in over 100 countries, focusing on animal care and health innovations.

Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. PT.

Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $7.8 billion in 2021 with approximately 12,100 employees. For more information, visit www.zoetis.com.

ZTS-COR
ZTS-IR

Media:

Bill Price

1-973-443-2742 (o)

william.price@zoetis.com

Kristen Seely

1-973-443-2777 (o)

kristen.seely@zoetis.com

Investors:

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com

Nick Soonthornchai

1-973-443-2792 (o)

nick.soonthornchai@zoetis.com

Source: Zoetis Inc.

FAQ

When is Zoetis presenting at the J.P. Morgan Healthcare Conference?

Zoetis is presenting on January 9, 2023, at 1:30 p.m. PT.

Who will represent Zoetis at the conference?

CEO Kristin Peck will represent Zoetis at the conference.

How can I access Zoetis' presentation at the conference?

You can access the live audio webcast of Zoetis' presentation on their investor relations website.

What was Zoetis' revenue in 2021?

Zoetis generated $7.8 billion in revenue in 2021.

In how many countries does Zoetis operate?

Zoetis operates in over 100 countries worldwide.

ZOETIS INC.

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Stock Data

79.51B
450.25M
0.2%
95.59%
0.96%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
PARSIPPANY